Xylem Inc. (XYL) reported $9.06B of revenue for the twelve months ended Sep 30, 2026. That is up 1.9% from the year before. Revenue for fiscal 2025 was $9.04B.

Yes. Xylem Inc. earned $1.08B in net income for the twelve months ended Sep 30, 2026, a net margin of 11.9%.

How much cash and debt does XYL have?

Xylem Inc. reported $708.00M in cash and cash equivalents and $2.90B of debt on its most recent balance sheet in SEC filings.

How fast is XYL revenue growing?

Xylem Inc.'s revenue changed +5.5% in fiscal 2025, to $9.04B. Its compound annual growth rate was +13.1% over 5 years and +9.5% over 10 years.

What is XYL gross margin?

Xylem Inc.'s gross profit was $3.60B on $9.06B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 39.8%.

What is XYL free cash flow?

Xylem Inc. generated $921.00M of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $1.27B less capital expenditures.

What is XYL earnings per share?

Diluted earnings per share were $4.52 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.

When did XYL last report financial results?

The latest statements here come from Xylem Inc.'s 10-Q filed on Oct 27, 2026, covering the period ended Sep 30, 2026.

Where does this XYL financial data come from?

Quantisnow builds these statements from the structured XBRL data Xylem Inc. files with the SEC. It is provided for information only and is not investment advice.

Financials · XYL

Xylem Inc. (XYL) financials

For the twelve months ended Sep 30, 2026, Xylem Inc. reported $9.06B of revenue and $1.08B of net income.

Revenue, TTM: $9.06B
Revenue growth, YoY: +1.9%
Net income, TTM: $1.08B
Net income growth, YoY: +14.1%
Net margin: 11.9%
Free cash flow, TTM: $921.00M
EPS, diluted, TTM: $4.52
EPS growth, YoY: +16.5%
Cash: $708.00M
Total debt: $2.90B
P/E: 20.74
P/S: 2.48
Market cap: $22.44B

Annual revenue$9.04B

FY2016FY2025

Annual net income$957.00M

FY2016FY2025

Annual free cash flow$910.00M

FY2016FY2025

XYL revenue and earnings growth

XYL revenueQ3 2026$2.20B

Quarter YoY: -3.0%
QoQ: -5.8%
FY YoY: +5.5%
5Y CAGR: +13.1%
10Y CAGR: +9.5%

XYL revenue was $2.20B in fiscal Q3 2026 (ended Sep 30, 2026), down 3.0% from a year earlier and down 5.8% from the prior quarter. For the full fiscal 2025 it was $9.04B, up 5.5% from fiscal 2024. Compound annual growth was +13.1% over 5 years and +9.5% over 10 years. It rose in 9 of the last 10 fiscal years. Fiscal 2025 is the highest of the 15 fiscal years on file.

XYL net incomeQ3 2026$291.00M

Quarter YoY: +28.2%
QoQ: +10.6%
FY YoY: +7.5%
5Y CAGR: +30.4%
10Y CAGR: +10.9%

XYL net income was $291.00M in fiscal Q3 2026 (ended Sep 30, 2026), up 28.2% from a year earlier and up 10.6% from the prior quarter. For the full fiscal 2025 it was $957.00M, up 7.5% from fiscal 2024. Compound annual growth was +30.4% over 5 years and +10.9% over 10 years. It rose in 6 of the last 10 fiscal years. Fiscal 2025 is the highest of the 15 fiscal years on file.

XYL EPSQ3 2026$1.25

Quarter YoY: +34.4%
QoQ: +12.6%
FY YoY: +7.4%
5Y CAGR: +22.9%
10Y CAGR: +7.7%

XYL diluted EPS was $1.25 in fiscal Q3 2026 (ended Sep 30, 2026), up 34.4% from a year earlier and up 12.6% from the prior quarter. For the full fiscal 2025 it was $3.92, up 7.4% from fiscal 2024. Compound annual growth was +22.9% over 5 years and +7.7% over 10 years.

XYL free cash flowQ3 2026$242.00M

Quarter YoY: -13.9%
QoQ: +20.4%
FY YoY: -3.4%
5Y CAGR: +7.3%
10Y CAGR: +10.1%

XYL free cash flow was $242.00M in fiscal Q3 2026 (ended Sep 30, 2026), down 13.9% from a year earlier and up 20.4% from the prior quarter. For the full fiscal 2025 it was $910.00M, down 3.4% from fiscal 2024. Compound annual growth was +7.3% over 5 years and +10.1% over 10 years. It rose in 7 of the last 10 fiscal years.

Export CSV

Income statement

Income statement
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Revenue	$9.04B	$8.56B	$7.36B	$5.52B	$5.20B	$4.88B	$5.25B	$5.21B	$4.71B	$3.77B
Cost of revenue	$5.56B	$5.35B	$4.65B	$3.44B	$3.22B	$3.05B	$3.20B	$3.18B	$2.86B	$2.31B
Gross profit	$3.48B	$3.21B	$2.72B	$2.08B	$1.98B	$1.83B	$2.05B	$2.03B	$1.85B	$1.46B
Research and development	$226.00M	$230.00M	$232.00M	$206.00M	$204.00M	$187.00M	$191.00M	$189.00M	$181.00M	$110.00M
Selling, general and admin	$1.92B	$1.91B	$1.76B	$1.23B	$1.18B	$1.14B	$1.16B	$1.16B	$1.09B	$914.00M
Operating income	$1.22B	$1.01B	$652.00M	$622.00M	$585.00M	$367.00M	$486.00M	$654.00M	$552.00M	$408.00M
Interest expense	$29.00M	$44.00M	$49.00M	$50.00M	$76.00M	$77.00M	$67.00M	$82.00M	$82.00M	$70.00M
Pre-tax income	$1.18B	$1.09B	$635.00M	$440.00M	$511.00M	$285.00M	$416.00M	$585.00M	$466.00M	$340.00M
Income tax	$231.00M	$197.00M	$26.00M	$85.00M	$84.00M	$31.00M	$15.00M	$36.00M	$136.00M	$80.00M
Net income	$957.00M	$890.00M	$609.00M	$355.00M	$427.00M	$254.00M	$401.00M	$549.00M	$331.00M	$260.00M
EPS, basic	$3.93	$3.67	$2.81	$1.97	$2.37	$1.41	$2.23	$3.05	$1.84	$1.45
EPS, diluted	$3.92	$3.65	$2.79	$1.96	$2.35	$1.40	$2.21	$3.03	$1.83	$1.45
Diluted shares	244.0M	243.5M	218.2M	181.0M	181.5M	181.1M	181.2M	181.1M	180.9M	180.0M

Balance sheet

Balance sheet
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Cash and equivalents	$1.48B	$1.12B	$1.02B	$944.00M	$1.35B	$1.88B	$724.00M	$296.00M	$414.00M	$308.00M
Short-term investments	-	-	-	-	-	-	$0	-	-	-
Receivables	$1.76B	$1.67B	$1.62B	$1.10B	$953.00M	$923.00M	$1.04B	$1.03B	$956.00M	$843.00M
Inventory	$983.00M	$996.00M	$1.02B	$799.00M	$700.00M	$558.00M	$539.00M	$595.00M	$524.00M	$522.00M
Current assets	$4.64B	$4.10B	$3.88B	$3.01B	$3.16B	$3.52B	$2.45B	$2.09B	$2.07B	$1.84B
Goodwill	$8.33B	$7.98B	$7.59B	$2.72B	$2.79B	$2.85B	$2.84B	$2.98B	$2.77B	$2.63B
Total assets	$17.63B	$16.49B	$16.11B	$7.95B	$8.28B	$8.75B	$7.71B	$7.22B	$6.86B	$6.47B
Current liabilities	$2.86B	$2.34B	$2.21B	$1.59B	$1.39B	$1.96B	$1.50B	$1.39B	$1.10B	$1.24B
Short-term debt	$534.00M	$38.00M	$16.00M	$0	$0	$600.00M	$276.00M	$257.00M	$0	$260.00M
Long-term debt	$1.41B	$1.98B	$2.27B	$1.88B	$2.44B	$2.48B	$2.04B	$2.05B	$2.20B	$2.11B
Total debt	$1.94B	$2.02B	$2.28B	$1.88B	$2.44B	$3.08B	$2.32B	$2.31B	$2.20B	$2.37B
Total liabilities	$5.88B	$5.61B	$5.94B	$4.45B	$5.05B	$5.77B	$4.74B	$4.44B	$4.34B	$4.27B
Shareholders' equity	$11.48B	$10.65B	$10.18B	$3.50B	$3.23B	$2.98B	$2.97B	$2.78B	$2.52B	$2.21B

Cash flow

Cash flow
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Operating cash flow	$1.24B	$1.26B	$837.00M	$596.00M	$538.00M	$824.00M	$839.00M	$586.00M	$686.00M	$497.00M
Capital expenditures	$331.00M	$321.00M	$271.00M	$208.00M	$208.00M	$183.00M	$226.00M	$237.00M	$170.00M	$124.00M
Free cash flow	$910.00M	$942.00M	$566.00M	$388.00M	$330.00M	$641.00M	$613.00M	$349.00M	$516.00M	$373.00M
Investing cash flow	-$471.00M	-$482.00M	-$628.00M	-$191.00M	-$183.00M	-$169.00M	-$231.00M	-$643.00M	-$181.00M	-$1.89B
Financing cash flow	-$501.00M	-$615.00M	-$157.00M	-$790.00M	-$855.00M	$473.00M	-$177.00M	-$40.00M	-$421.00M	$1.03B
Dividends paid	$391.00M	$350.00M	$299.00M	$217.00M	$203.00M	$188.00M	$174.00M	$152.00M	$130.00M	$112.00M
Share repurchases	$15.00M	$20.00M	$25.00M	$52.00M	$68.00M	$61.00M	$40.00M	$59.00M	$25.00M	$4.00M
Stock-based compensation	$53.00M	$56.00M	$60.00M	$37.00M	$33.00M	$26.00M	$29.00M	$30.00M	$21.00M	$18.00M
Depreciation and amortization	$575.00M	$562.00M	$436.00M	$236.00M	$245.00M	$251.00M	$257.00M	$261.00M	$234.00M	$151.00M

Key ratios

Key ratios
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Revenue growth, YoY	5.5%	16.3%	33.4%	6.3%	6.5%	-7.1%	0.8%	10.6%	24.8%	3.2%
Net income growth, YoY	7.5%	46.1%	71.5%	-16.9%	68.1%	-36.7%	-27.0%	65.9%	27.3%	-23.5%
EPS growth, YoY	7.4%	30.8%	42.3%	-16.6%	67.9%	-36.7%	-27.1%	65.6%	26.2%	-22.5%
Gross margin	38.5%	37.5%	36.9%	37.7%	38.0%	37.5%	39.0%	38.9%	39.2%	38.8%
Operating margin	13.5%	11.8%	8.9%	11.3%	11.3%	7.5%	9.3%	12.6%	11.7%	10.8%
Net margin	10.6%	10.4%	8.3%	6.4%	8.2%	5.2%	7.6%	10.5%	7.0%	6.9%
Free cash flow margin	10.1%	11.0%	7.7%	7.0%	6.4%	13.1%	11.7%	6.7%	11.0%	9.9%
Return on equity	8.3%	8.4%	6.0%	10.1%	13.2%	8.5%	13.5%	19.7%	13.1%	11.8%
Return on assets	5.4%	5.4%	3.8%	4.5%	5.2%	2.9%	5.2%	7.6%	4.8%	4.0%
Current ratio	1.63	1.75	1.76	1.89	2.27	1.80	1.63	1.51	1.88	1.49
Debt to equity	0.17	0.19	0.22	0.54	0.76	1.04	0.78	0.83	0.87	1.07

Income statement

Income statement
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Revenue	$2.20B	$2.34B	$2.13B	$2.40B	$2.27B	$2.30B	$2.07B	$2.26B	$2.10B	$2.17B	$2.03B	$2.12B
Cost of revenue	$1.29B	$1.37B	$1.32B	$1.47B	$1.39B	$1.41B	$1.30B	$1.40B	$1.32B	$1.35B	$1.28B	$1.36B
Gross profit	$907.00M	$963.00M	$803.00M	$932.00M	$883.00M	$892.00M	$768.00M	$857.00M	$784.00M	$819.00M	$752.00M	$756.00M
Research and development	$56.00M	$59.00M	$56.00M	$60.00M	$52.00M	$58.00M	$56.00M	$58.00M	$55.00M	$58.00M	$59.00M	$60.00M
Selling, general and admin	$458.00M	$503.00M	$472.00M	$486.00M	$474.00M	$503.00M	$460.00M	$507.00M	$445.00M	$485.00M	$474.00M	$466.00M
Operating income	$385.00M	$390.00M	$244.00M	$353.00M	$334.00M	$305.00M	$231.00M	$267.00M	$280.00M	$253.00M	$209.00M	$211.00M
Interest expense	$21.00M	$7.00M	$4.00M	$6.00M	$6.00M	$9.00M	$8.00M	$9.00M	$10.00M	$11.00M	$14.00M	$14.00M
Pre-tax income	$365.00M	$364.00M	$244.00M	$368.00M	$297.00M	$299.00M	$217.00M	$375.00M	$269.00M	$247.00M	$196.00M	$210.00M
Income tax	$77.00M	$103.00M	$55.00M	$35.00M	$71.00M	$75.00M	$50.00M	$49.00M	$52.00M	$53.00M	$43.00M	-$56.00M
Net income	$291.00M	$263.00M	$193.00M	$335.00M	$227.00M	$226.00M	$169.00M	$326.00M	$217.00M	$194.00M	$153.00M	$266.00M
EPS, basic	$1.25	$1.11	$0.79	$1.38	$0.93	$0.93	$0.69	$1.35	$0.89	$0.80	$0.63	-
EPS, diluted	$1.25	$1.11	$0.79	$1.37	$0.93	$0.93	$0.69	$1.33	$0.89	$0.80	$0.63	-
Diluted shares	233.0M	236.6M	243.4M	-	244.1M	243.9M	243.8M	-	243.8M	243.5M	243.0M	-

Balance sheet

Balance sheet
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Cash and equivalents	$708.00M	$1.28B	$808.00M	$1.48B	$1.19B	$1.17B	$1.06B	$1.12B	$989.00M	$815.00M	$947.00M	$1.02B
Receivables	$1.97B	$1.88B	$1.80B	$1.76B	$1.80B	$1.84B	$1.74B	$1.67B	$1.71B	$1.68B	$1.64B	$1.62B
Inventory	$1.05B	$1.02B	$991.00M	$983.00M	$1.03B	$1.07B	$1.02B	$996.00M	$1.09B	$1.06B	$1.04B	$1.02B
Current assets	$3.95B	$4.39B	$4.03B	$4.64B	$4.44B	$4.37B	$4.08B	$4.10B	$4.01B	$3.78B	$3.89B	$3.88B
Goodwill	$8.52B	$8.26B	$8.29B	$8.33B	$8.28B	$8.24B	$8.06B	$7.98B	$7.59B	$7.51B	$7.51B	$7.59B
Total assets	$17.33B	$17.34B	$16.95B	$17.63B	$17.30B	$17.19B	$16.56B	$16.49B	$16.05B	$15.77B	$15.92B	$16.11B
Current liabilities	$2.84B	$2.72B	$2.75B	$2.86B	$2.27B	$2.30B	$2.17B	$2.34B	$2.05B	$2.04B	$2.33B	$2.21B
Short-term debt	$530.00M	$531.00M	$531.00M	$534.00M	$49.00M	$68.00M	$41.00M	$38.00M	$17.00M	$17.00M	$285.00M	$16.00M
Long-term debt	$2.37B	$2.40B	$1.41B	$1.41B	$1.91B	$1.93B	$1.97B	$1.98B	$1.98B	$1.98B	$1.99B	$2.27B
Total debt	$2.90B	$2.93B	$1.94B	$1.94B	$1.96B	$2.00B	$2.02B	$2.02B	$1.99B	$2.00B	$2.27B	$2.28B
Total liabilities	$6.82B	$6.68B	$5.72B	$5.88B	$5.85B	$5.88B	$5.50B	$5.61B	$5.45B	$5.42B	$5.72B	$5.94B
Shareholders' equity	$10.27B	$10.42B	$10.98B	$11.48B	$11.22B	$11.08B	$10.82B	$10.65B	$10.60B	$10.35B	$10.20B	$10.18B

Cash flow

Cash flow
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Operating cash flow	$331.00M	$290.00M	$108.00M	$543.00M	$360.00M	$305.00M	$33.00M	$575.00M	$311.00M	$288.00M	$89.00M	$455.00M
Capital expenditures	$89.00M	$89.00M	$90.00M	$83.00M	$79.00M	$98.00M	$71.00M	$100.00M	$74.00M	$73.00M	$74.00M	$94.00M
Free cash flow	$242.00M	$201.00M	$18.00M	$460.00M	$281.00M	$207.00M	-$38.00M	$475.00M	$237.00M	$215.00M	$15.00M	$361.00M
Investing cash flow	-$456.00M	-$22.00M	-$76.00M	-$142.00M	-$189.00M	-$125.00M	-$15.00M	-$289.00M	-$65.00M	-$77.00M	-$51.00M	-$89.00M
Financing cash flow	-$451.00M	$199.00M	-$683.00M	-$119.00M	-$138.00M	-$128.00M	-$116.00M	-$95.00M	-$101.00M	-$337.00M	-$82.00M	-$86.00M
Dividends paid	$100.00M	$101.00M	$106.00M	$98.00M	$97.00M	$98.00M	$98.00M	$87.00M	$88.00M	$87.00M	$88.00M	$80.00M
Share repurchases	$337.00M	$680.00M	$563.00M	$1.00M	$1.00M	$0	$13.00M	$1.00M	$1.00M	$3.00M	$15.00M	$15.00M
Stock-based compensation	$14.00M	$12.00M	$13.00M	$16.00M	$12.00M	$13.00M	$12.00M	$13.00M	$12.00M	$13.00M	$18.00M	$15.00M
Depreciation and amortization	-	-	-	$143.00M	-	-	-	$142.00M	$141.00M	$145.00M	$134.00M	$137.00M

Key ratios

Key ratios
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Revenue growth, YoY	-3.0%	1.5%	2.7%	6.3%	7.8%	6.1%	1.8%	6.5%	1.3%	26.0%	40.4%	40.6%
Net income growth, YoY	28.2%	16.4%	14.2%	2.8%	4.6%	16.5%	10.5%	22.6%	42.8%	110.9%	54.5%	78.5%
EPS growth, YoY	34.4%	19.4%	14.5%	3.0%	4.5%	16.3%	9.5%	-	41.3%	77.8%	16.7%	-
Gross margin	41.2%	41.2%	37.8%	38.9%	38.9%	38.8%	37.1%	38.0%	37.3%	37.8%	37.0%	35.7%
Operating margin	17.5%	16.7%	11.5%	14.7%	14.7%	13.3%	11.2%	11.8%	13.3%	11.7%	10.3%	10.0%
Net margin	13.2%	11.3%	9.1%	14.0%	10.0%	9.8%	8.2%	14.5%	10.3%	8.9%	7.5%	12.6%
Free cash flow margin	11.0%	8.6%	0.8%	19.2%	12.4%	9.0%	-1.8%	21.1%	11.3%	9.9%	0.7%	17.0%
Current ratio	1.39	1.61	1.46	1.63	1.96	1.90	1.89	1.75	1.96	1.85	1.67	1.76
Debt to equity	0.28	0.28	0.18	0.17	0.17	0.18	0.19	0.19	0.19	0.19	0.22	0.22

Source: XBRL data Xylem Inc. files with the SEC, latest filing dated Oct 27, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

XYL peers

Company	Revenue	Growth	Net income	Net margin	Market cap
XYL	$9.06B	+1.9%	$1.08B	11.9%	$22.44B
ITTITT Inc.	$5.18B	+35.8%	$418.20M	8.1%	$18.38B
IEXIDEX Corporation	$3.66B	+6.9%	$535.80M	14.6%	$16.67B
GGGGraco Inc.	$2.31B	+5.4%	$517.48M	22.4%	$10.88B
FLSFlowserve Corporation	$4.70B	+0.2%	$254.72M	5.4%	$10.19B
GRCGorman-Rupp Company	$722.48M	+6.5%	$73.73M	10.2%	$1.79B
APAmpco-Pittsburgh Corporation	$428.04M	+3.3%	-$59.25M	-13.8%	$121.7M

XYL FAQ

9 questions

What is XYL revenue?
Xylem Inc. (XYL) reported $9.06B of revenue for the twelve months ended Sep 30, 2026. That is up 1.9% from the year before. Revenue for fiscal 2025 was $9.04B.
Is XYL profitable?
Yes. Xylem Inc. earned $1.08B in net income for the twelve months ended Sep 30, 2026, a net margin of 11.9%.
How much cash and debt does XYL have?
Xylem Inc. reported $708.00M in cash and cash equivalents and $2.90B of debt on its most recent balance sheet in SEC filings.
How fast is XYL revenue growing?
Xylem Inc.'s revenue changed +5.5% in fiscal 2025, to $9.04B. Its compound annual growth rate was +13.1% over 5 years and +9.5% over 10 years.
What is XYL gross margin?
Xylem Inc.'s gross profit was $3.60B on $9.06B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 39.8%.
What is XYL free cash flow?
Xylem Inc. generated $921.00M of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $1.27B less capital expenditures.
What is XYL earnings per share?
Diluted earnings per share were $4.52 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.
When did XYL last report financial results?
The latest statements here come from Xylem Inc.'s 10-Q filed on Oct 27, 2026, covering the period ended Sep 30, 2026.
Where does this XYL financial data come from?
Quantisnow builds these statements from the structured XBRL data Xylem Inc. files with the SEC. It is provided for information only and is not investment advice.